Craniectomy Protocol

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

62 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-06-30

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this protocol is to evaluate the quality of life and functional disability in the long term (2 years after craniectomy) in subject's victims of malignant Sylvien stroke who received a decompressive craniotomy in the acute phase. Patients who have given their consent to be evaluated at least two years after their stroke and their operation in a single visit by clinical examination and procurement of standardized scales. Will be measured the quality of life through scale SIS3.0, residual disability by the Rankin scale. The quality of life of the carer will be assessed through scales and Zarit carer version of SIS3.0. The existence of predictive parameters of long-term evolution will be searched in determining the existence of a correlation between demographic data and baseline characteristics of the stroke on and the evolution of the quality of life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Good Prognosis Factors After Decompressive Craniectomy : a Ten-year Retrospective Study

NCT04682951

Decompressive Craniectomy Brain Injuries Treatment Outcome

COMPLETED

Decompressive Craniectomy In Malignant Middle Cerebral Artery Infarcts

NCT00190203

Malignant Middle Cerebral Artery Infarction

TERMINATED PHASE3

The AGAINST Protocol: Augmentative Craniotomy in Stroke

NCT05860855

Middle Cerebral Artery Occlusion With Cerebral Infarction

UNKNOWN NA

Impact of Cranioplasty On Cerebral Perfusion

NCT01113645

Head Injuries Subarachnoid Haemorrhage Intra-cerebral Haemorrhage +2 more

COMPLETED

Decompressive Craniectomy Combined With Hematoma Removal to Treat ICH

NCT02135783

Intracranial Hemorrhages

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke Decompressive Craniectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

craniectomy

Adult subjects who experienced a cerebral infarction extended the sylvian area, and having received treatment by decompressive craniectomy.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age\> = 18 years
* Having presented an ischemic stroke involving the sylvian area
* Having received decompressive craniectomy in acute ischemic stroke
* Time between stroke and the inclusion of at least 24 months
* Signed informed consent
* Patient affiliated to a social security system

Exclusion Criteria

* Patients with a Rankin score before stroke than or equal to 3
* Stroke in multiple territories (contralateral carotid and / or vertebrobasilar) associated with stroke in the acute phase describing which in the opinion of the investigator significantly influence the long-term functional prognosis
* Cognitive deterioration or severe aphasia making it impossible to fill out questionnaires
* Minors
* Major under curators

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No